ASCO25 Primer: Navigating Cancer R&D Amid Regulatory Uncertainty

The 2025 ASCO Annual Meeting highlights major advances in diagnostics, immunotherapy, and precision medicine, reflecting the rapidly evolving oncology landscape12.

Key research presentations include novel approaches to treating glioblastoma, brain metastases, breast, testicular, and bladder cancers, as well as studies in liquid biopsy and combination immunotherapy for rare tumors5.

Experts and thought leaders are actively discussing regulatory changes and uncertainties, particularly proposed modifications to federal health agencies that could impact future cancer research and development4.

Award-winning research, such as that recognized by ASCO's Conquer Cancer Merit Award, emphasizes the high-quality innovation and collaborative efforts driving new cancer treatments5.

The meeting provides a critical forum for sharing leading-edge findings and navigating the complex intersection of research, clinical care, and policy shifts in oncology34.

Sources:

1. https://www.asco.org/about-asco/press-center/news-releases/advances-diagnostics-immunotherapy-precision-medicine-2025-asco-annual-meeting-press-program

2. https://www.asco.org/annual-meeting

3. https://www.cityofhope.org/asco25

4. https://ascopost.com/news/may-2025/asco-proposed-changes-to-federal-health-agencies-threaten-future-cancer-research-advancements/

5. https://baptisthealth.net/newsroom/press-release/miami-cancer-institute-to-present-latest-research-at-2025-asco